Expert Insights

home News and Events Expert Insights

Good Manufacturing Practices complementary to Experimental Drugs(ANVISA- BRAZIL)

  • Writer Priscilla, Lima Viana Palhano
  • Date 2021-01-05
  • Views 1,900

Guide for Good Manufacturing Practices complementary to Experimental Drugs, according to ANVISA- BRAZIL



-Abstract : This Normative Instruction is intended to adopt the Good Practice Guidelines for the Manufacturing of Experimental Drugs from the Pharmaceutical Inspection Cooperation Scheme, PIC/S, as complementary requirements to be followed in the manufacture of experimental drugs in addition to the General Good Practice Guidelines for Drug Manufacturing.